GO:0060101 negative regulation of phagocytosis, engulfment

Phagocytosis is a fundamental innate immune process by which cells internalize bacteria, immune complexes, apoptotic cells, and other particulate matter. While much attention has focused on the positive regulation of engulfment, the mechanisms that stop or dampen phagocytosis are equally critical for resolving inflammation and maintaining tissue homeostasis [2, 7]. The Gene Ontology term GO:0060101, negative regulation of phagocytosis, engulfment, captures this essential braking system [2, 3]. Understanding how engulfment is negatively regulated has broad implications for immunology, neurobiology, and disease pathogenesis [4, 5, 7]. Research over the past decade has identified diverse molecular players that restrain phagocytic activity. In Drosophila glia, the engulfment receptor Draper is downregulated after axon injury to terminate glial responses, illustrating a negative feedback loop that prevents excessive engulfment. In mammalian macrophages, neuraminidase 1 (NEU1) modulates phagocytic capacity, and its loss alters the clearance of particles. Rubicon (RUBCN) has emerged as a negative regulator of phagocytosis and autophagy, with roles in metabolic diseases and ageing. TREM2, a receptor expressed on microglia and macrophages, can either promote or inhibit phagocytosis depending on context, and its function is critical during bacterial infection. Additionally, activated Src kinase has been shown to promote cell cannibalism in Drosophila, a process related to but distinct from classical phagocytosis. These examples highlight the complexity and context-dependence of negative regulation of engulfment. For researchers, GO:0060101 provides a framework to systematically study the genes and pathways that limit phagocytosis. This article synthesizes current knowledge from authoritative QuickGO annotations and peer-reviewed literature, and outlines how CRISPR-based models can be used to dissect these mechanisms. By targeting negative regulators, it is possible to enhance or restore phagocytic function in disease settings, or conversely, to prevent pathological engulfment in neuroinflammation and autoimmunity [2, 4, 5].

GO:0060101, negative regulation of phagocytosis, engulfment, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of the internalization of bacteria, immune complexes, and other particulate matter, or of an apoptotic cell by phagocytosis. In simpler terms, it encompasses all molecular events that put the brakes on engulfment, ensuring that phagocytes do not over-consume targets and that inflammatory responses are appropriately terminated [2, 3, 7].

Negative regulation of phagocytosis, engulfment is critical for preventing excessive inflammation and tissue damage. Without proper braking mechanisms, phagocytes can chronically engulf apoptotic cells or pathogens, leading to autoimmune reactions, chronic inflammation, and neurodegeneration [2, 7]. Moreover, pathogens can exploit negative regulators to evade clearance, as seen with TREM2 modulation during bacterial infection. Understanding GO:0060101 is therefore essential for developing therapies that either enhance pathogen clearance or dampen pathological engulfment in sterile inflammatory diseases [4, 5].

The following genes and proteins have been experimentally implicated in the negative regulation of phagocytosis, engulfment, based on the verified literature.

Negative regulation of phagocytosis, engulfment is itself tightly regulated at multiple levels. Transcriptional downregulation of engulfment receptors, such as Draper in Drosophila glia, terminates engulfment after injury. Post-translational modifications, including sialylation by NEU1, modulate receptor activity. Rubicon (RUBCN) acts as a negative regulator by inhibiting PI3K complexes, and its expression is linked to metabolic status and ageing. TREM2 signaling can be modulated by bacterial ligands, leading to either enhanced or suppressed phagocytosis depending on context. Additionally, Src kinase activity is kept in check by negative regulators to prevent cell cannibalism. These layers of regulation ensure that phagocytosis is appropriately terminated.

In neurodegenerative conditions, excessive microglial or glial engulfment of synapses and healthy neurons contributes to pathology. Negative regulation of engulfment, such as Draper downregulation in Drosophila glia, is protective by terminating glial responses to axon injury. TREM2, a key microglial receptor, is genetically linked to Alzheimer's disease, and its role in negative regulation of phagocytosis may influence disease progression. Rubicon has also been implicated in ageing and metabolic diseases that affect brain function.

Rubicon (RUBCN) is a negative regulator of phagocytosis and autophagy, and its dysregulation is associated with metabolic diseases and accelerated ageing. Loss of Rubicon leads to enhanced phagocytosis, which can alter lipid metabolism and energy homeostasis. Thus, negative regulation of engulfment is important for metabolic health.

TREM2 modulates phagocytosis during bacterial infection, and its negative regulation can either promote or impair pathogen clearance depending on the bacterial species. Pathogens may exploit negative regulators to evade phagocytosis. Understanding these mechanisms is crucial for developing therapies against intracellular bacteria.

Defective negative regulation of apoptotic cell engulfment can lead to secondary necrosis and autoimmunity. The immunological rites of cell death require precise termination of phagocytosis to avoid chronic inflammation. Neuraminidase 1 (NEU1) deficiency in macrophages alters phagocytosis and may contribute to autoimmune phenotypes.

Quantitative phagocytosis assays using fluorescent bacteria, zymosan, or apoptotic cells are standard to measure engulfment rates. These assays can be combined with CRISPR knockout of candidate negative regulators to assess changes in phagocytic index [2, 3, 5].

Live imaging of phagocytic cup formation and resolution allows real-time visualization of negative regulation. Fluorescently tagged receptors (e.g., Draper, TREM2) and actin markers can reveal termination dynamics [2, 8].

Flow cytometry quantifies internalization of fluorescent particles or apoptotic cells on a per-cell basis. It is useful for screening CRISPR libraries targeting negative regulators [3, 5].

RNA-seq and proteomics can identify genes and proteins differentially expressed upon negative regulation. For example, Rubicon-dependent changes in metabolic pathways can be uncovered.

Researchers studying negative regulation of phagocytosis, engulfment-related genes often need to determine whether a candidate gene is causally involved in limiting engulfment. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models, enabling functional validation of negative regulators in relevant phagocyte backgrounds.

GO:0060101, negative regulation of phagocytosis, engulfment, represents a critical braking system that prevents excessive or prolonged phagocytic activity. Dysregulation of this process contributes to neurodegeneration, metabolic diseases, autoimmunity, and impaired host defense [2, 4, 5, 7]. The genes and pathways highlighted here, including Draper, NEU1, RUBCN, TREM2, and Src, provide a starting point for mechanistic studies. CRISPR-based models are indispensable for causally linking these genes to engulfment phenotypes. EDITGENE offers comprehensive services to accelerate such research, from knockout and knock-in cell lines to library screening and bioinformatics.